Cargando…

Correction: PO-194 Novel potential targets for hakai oncogene during tumour progression

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6278176/ https://www.ncbi.nlm.nih.gov/pubmed/30592465 http://dx.doi.org/10.1136/esmoopen-2018-EACR25.230corr1

Ejemplares similares

Hakai overexpression effectively induces tumour progression and metastasis in vivo
por: Castosa, Raquel, et al.
Publicado: (2018)

Biological influence of Hakai in cancer: a 10-year review
por: Aparicio, Luis A., et al.
Publicado: (2012)

Role of Hakai in m(6)A modification pathway in Drosophila
por: Wang, Yanhua, et al.
Publicado: (2021)

Hakai reduces cell-substratum adhesion and increases epithelial cell invasion
por: Rodríguez-Rigueiro, Teresa, et al.
Publicado: (2011)

Correction: Tumour-derived exosomal lncRNA-SOX2OT promotes bone metastasis of non-small cell lung cancer by targeting the miRNA-194-5p/RAC1 signalling axis in osteoclasts
por: Ni, Jianjiao, et al.
Publicado: (2021)

Correction: The Oncogene PDRG1 Is an Interaction Target of Methionine Adenosyltransferases
por: Pérez, Claudia, et al.
Publicado: (2016)

Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11
por: Liao, Yunfei, et al.
Publicado: (2018)

miR-203 Regulates Cell Proliferation through Its Influence on Hakai Expression
por: Abella, Vanessa, et al.
Publicado: (2012)

Two zinc finger proteins with functions in m(6)A writing interact with HAKAI
por: Zhang, Mi, et al.
Publicado: (2022)

Role of the E3 ubiquitin-ligase Hakai in intestinal inflammation and cancer bowel disease
por: Roca-Lema, Daniel, et al.
Publicado: (2022)

Correction: Reduced expression of AMPK-ß1 during tumor progression enhances the oncogenic capacity of advanced ovarian cancer
por: Li, Cuilan, et al.
Publicado: (2014)

Publisher Correction: miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia
por: Li, Zejuan, et al.
Publicado: (2018)

Correction: Fadraciclib (CYC065), a novel CDK inhibitor, targets key pro-survival and oncogenic pathways in cancer
Publicado: (2021)

Hakai is required for stabilization of core components of the m(6)A mRNA methylation machinery
por: Bawankar, Praveen, et al.
Publicado: (2021)

Hakin-1, a New Specific Small-Molecule Inhibitor for the E3 Ubiquitin-Ligase Hakai, Inhibits Carcinoma Growth and Progression
por: Martinez-Iglesias, Olaia, et al.
Publicado: (2020)

Correction: Caspase-1-Like Regulation of the proPO-System and Role of ppA and Caspase-1-Like Cleaved Peptides from proPO in Innate Immunity
por: Jearaphunt, Miti, et al.
Publicado: (2016)

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
por: Dong, Peixin, et al.
Publicado: (2011)

Correction: Acidity promotes tumour progression by altering macrophage phenotype in prostate cancer
por: El-Kenawi, Asmaa, et al.
Publicado: (2020)

Correction: Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2018)

Heat Shock Protein 90 Chaperone Regulates the E3 Ubiquitin-Ligase Hakai Protein Stability
por: Díaz-Díaz, Andrea, et al.
Publicado: (2020)

Daurisoline Inhibiting Tumor Angiogenesis and Epithelial-Mesenchymal Transition in Bladder Cancer by Mediating HAKAI Protein Stability
por: Huang, Keming, et al.
Publicado: (2022)

Correction: CCT3 acts upstream of YAP and TFCP2 as a potential target and tumour biomarker in liver cancer
por: Liu, Ya, et al.
Publicado: (2022)

Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
por: Orlando, Eleonora, et al.
Publicado: (2023)

Correction: Schwann cells support oncogenic potential of pancreatic cancer cells through TGFβ signaling
por: Roger, Elodie, et al.
Publicado: (2020)

Correction: Targeting oncogenic microRNAs from the miR-371~373 and miR-302/367 clusters in malignant germ cell tumours causes growth inhibition through cell cycle disruption
por: Bailey, Shivani, et al.
Publicado: (2023)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2016)

Correction: CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
por: Costa-Cabral, Sara, et al.
Publicado: (2017)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Correction to: Progesterone receptor membrane component 1 regulates lipid homeostasis and drives oncogenic signaling resulting in breast cancer progression
por: Asperger, Hannah, et al.
Publicado: (2021)

Correction: A novel mechanism of regulation of the oncogenic transcription factor GLI3 by toll-like receptor signaling
por: Matissek, Stephan J., et al.
Publicado: (2023)

Correction: A novel technique of serial biopsy in mouse brain tumour models
Publicado: (2019)

Correction for: LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2021)

Correction: Knockdown of SOX2OT inhibits the malignant biological behaviors of glioblastoma stem cells via up-regulating the expression of miR-194-5p and miR-122
por: Su, Rui, et al.
Publicado: (2022)

Competitive Regulation of E-Cadherin JuxtaMembrane Domain Degradation by p120-Catenin Binding and Hakai-Mediated Ubiquitination
por: Hartsock, Andrea, et al.
Publicado: (2012)

Ajuba inhibits hepatocellular carcinoma cell growth via targeting of β-catenin and YAP signaling and is regulated by E3 ligase Hakai through neddylation
por: Liu, Min, et al.
Publicado: (2018)

Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
por: Al-Jameel, Waseem, et al.
Publicado: (2020)

Correction to: Rank ectopic expression in the presence of Neu and PyMT oncogenes alters mammary epithelial cell populations and their tumorigenic potential
por: Cordero, Alex, et al.
Publicado: (2023)

Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer
por: Slootbeek, Peter H. J., et al.
Publicado: (2022)

Correction: Oncogenic states dictate the prognostic and predictive connotations of intratumoral immune response
Publicado: (2020)

Correction to: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies
por: Ahmadi, Seyed Esmaeil, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3jdmka6rimklkmc1u9df0t2ou0